Michael P. Link

19.6k total citations · 3 hit papers
145 papers, 9.9k citations indexed

About

Michael P. Link is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael P. Link has authored 145 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pathology and Forensic Medicine, 48 papers in Public Health, Environmental and Occupational Health and 45 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael P. Link's work include Lymphoma Diagnosis and Treatment (49 papers), Acute Lymphoblastic Leukemia research (45 papers) and Sarcoma Diagnosis and Treatment (39 papers). Michael P. Link is often cited by papers focused on Lymphoma Diagnosis and Treatment (49 papers), Acute Lymphoblastic Leukemia research (45 papers) and Sarcoma Diagnosis and Treatment (39 papers). Michael P. Link collaborates with scholars based in United States, Canada and Germany. Michael P. Link's co-authors include Sarah S. Donaldson, Allen M. Goorin, Jonathan J. Shuster, Holcombe E. Grier, Mark C. Gebhardt, Teresa J. Vietti, Alberto G. Ayala, Paul A. Meyers, Nancy J. Tarbell and Mark Krailo and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Michael P. Link

144 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

2003 948 citations Holcombe E. Grier, Mark Krailo et al. profile →
The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the Extremity

1986 903 citations Michael P. Link, Allen M. Goorin et al. profile →
Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

2008 520 citations Paul A. Meyers, Cindy L. Schwartz et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael P. Link United States	55	4.5k	2.5k	2.5k	2.0k	1.6k	145	9.9k
William M. Crist United States	44	4.9k 1.1×	2.6k 1.0×	2.6k 1.0×	1.9k 0.9×	1.6k 1.0×	145	9.5k
Holcombe E. Grier United States	57	5.7k 1.3×	1.8k 0.7×	2.4k 0.9×	2.5k 1.2×	2.0k 1.3×	145	11.7k
Charles B. Pratt United States	50	3.7k 0.8×	1.4k 0.6×	2.8k 1.1×	1.2k 0.6×	1.7k 1.1×	198	8.5k
Jeremy Whelan United Kingdom	48	5.2k 1.2×	1.8k 0.7×	3.4k 1.4×	980 0.5×	1.4k 0.9×	194	9.6k
Carlos Rodríguez‐Galindo United States	63	3.7k 0.8×	1.6k 0.7×	4.1k 1.6×	1.4k 0.7×	3.5k 2.2×	356	13.7k
Norman Jaffe United States	54	4.4k 1.0×	1.1k 0.4×	2.5k 1.0×	1.0k 0.5×	1.9k 1.2×	201	9.8k
Heribert Jürgens Germany	48	7.5k 1.7×	1.6k 0.6×	3.2k 1.3×	725 0.4×	2.3k 1.5×	186	11.9k
Thierry Philip France	52	3.3k 0.7×	4.6k 1.8×	4.8k 1.9×	1.3k 0.6×	999 0.6×	277	12.0k
Paul A. Meyers United States	66	9.0k 2.0×	2.1k 0.8×	4.2k 1.7×	756 0.4×	2.3k 1.5×	262	15.7k
Rochelle E. Curtis United States	53	2.2k 0.5×	2.7k 1.1×	4.3k 1.7×	1.6k 0.8×	1.7k 1.1×	109	11.2k

Countries citing papers authored by Michael P. Link

Since Specialization

Citations

This map shows the geographic impact of Michael P. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Link more than expected).

Fields of papers citing papers by Michael P. Link

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Link. The network helps show where Michael P. Link may publish in the future.

Co-authorship network of co-authors of Michael P. Link

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Link. A scholar is included among the top collaborators of Michael P. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Link. Michael P. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Link, Michael P., et al.. (2025). Potential Region-Specific Neuroprotective Effects of Kynurenine Administration in Healthy Rodents Using High-Resolution Mass Spectrometry. ACS Chemical Neuroscience. 16(19). 3682–3693.

Chen, Yan, Yutaka Yasui, Rachel Phelan, et al.. (2024). Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS). Pediatric Blood & Cancer. 71(10). e31189–e31189. 2 indexed citations

Theruvath, Ashok J., Florian Siedek, Anne M. Muehe, et al.. (2020). Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI. Radiology. 296(1). 143–151. 24 indexed citations

Chamberlain, Lisa, Noelle Pineda, Lena E. Winestone, et al.. (2014). Increased Utilization of Pediatric Specialty Care. Journal of Pediatric Hematology/Oncology. 36(2). 99–107. 19 indexed citations

Thakral, Charu, R. Hutchison, Antony E. Shrimpton, et al.. (2012). ALK+ anaplastic large cell lymphoma exhibits phosphatidylinositol‐3 kinase/akt activity with retained but inactivated PTEN—A report from the Children's Oncology Group. Pediatric Blood & Cancer. 59(3). 440–447. 3 indexed citations

Meyers, Paul A., Cindy L. Schwartz, Mark Krailo, et al.. (2008). Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group. Journal of Clinical Oncology. 26(4). 633–638. 520 indexed citations breakdown →

Hutchison, R., Joseph Laver, Myron Chang, et al.. (2008). Non‐anaplastic peripheral t‐cell lymphoma in childhood and adolescence: A Children's Oncology Group study. Pediatric Blood & Cancer. 51(1). 29–33. 39 indexed citations

Donaldson, Sarah S., Michael P. Link, Howard J. Weinstein, et al.. (2007). Final Results of a Prospective Clinical Trial With VAMP and Low-Dose Involved-Field Radiation for Children With Low-Risk Hodgkin's Disease. Journal of Clinical Oncology. 25(3). 332–337. 86 indexed citations

Miser, James S., Robert E. Goldsby, Zhengjia Chen, et al.. (2007). Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: Evaluation of increasing the dose intensity of chemotherapy—a report from the Children's Oncology Group. Pediatric Blood & Cancer. 49(7). 894–900. 77 indexed citations

10.

Foliart, Donna E., Brad H. Pollock, G. Mezei, et al.. (2006). Magnetic field exposure and long-term survival among children with leukaemia. British Journal of Cancer. 94(1). 161–164. 36 indexed citations

11.

Shuster, Jonathan J., et al.. (2002). Minimax two‐stage‐designs with applications to tissue banking case‐control studies. Statistics in Medicine. 21(17). 2479–2493. 6 indexed citations

12.

Ferguson, William S., Michael B. Harris, Allen M. Goorin, et al.. (2001). Presurgical Window of Carboplatin and Surgery and Multidrug Chemotherapy for the Treatment of Newly Diagnosed Metastatic or Unresectable Osteosarcoma: Pediatric Oncology Group Trial. The American journal of pediatric hematology/oncology. 23(6). 340–348. 52 indexed citations

13.

Harris, Michael B., Peter W. Gieser, Allen M. Goorin, et al.. (1998). Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study.. Journal of Clinical Oncology. 16(11). 3641–3648. 137 indexed citations

14.

Donaldson, Sarah S., Michael P. Link, Arvin S. Glicksman, et al.. (1998). A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346. International Journal of Radiation Oncology*Biology*Physics. 42(1). 125–135. 137 indexed citations

15.

Link, Michael P., Eliza Ng, Jonathan J. Shuster, et al.. (1997). Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.. Journal of Clinical Oncology. 15(3). 1158–1162. 41 indexed citations

16.

Goorin, Allen M., Douglas Strother, David G. Poplack, et al.. (1995). Safety and Efficacy of I‐Leucovorin Rescue Following High‐Dose Methotrexate for Osteosarcoma. Medical and Pediatric Oncology. 24(6). 362–367. 12 indexed citations

17.

Crist, W M, J J Shuster, Thomas Look, et al.. (1992). Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. Leukemia. 6. 162–165. 28 indexed citations

18.

Grier, Holcombe E., Richard D. Gelber, Luis A. Clavell, et al.. (1990). Intensive Sequential Chemotherapy for Children with Acute Myelogenous Leukemia. Hämatologie und Bluttransfusion. 33. 193–197. 6 indexed citations

19.

Wright, Ann, Michael P. Link, SD Smith, et al.. (1989). Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain.. The Journal of Experimental Medicine. 169(5). 1557–1564. 84 indexed citations

20.

Carroll, W L, et al.. (1989). Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma.. The Journal of Immunology. 143(2). 692–698. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact